|
|
|
![]() |
RELATIVE RISK
OF INDIVIDUAL COMPLICATIONS: (BMI 25-30) Pancreatitis Cataracts Asthma Non alcoholic steatohepatitis Phlebitis
Depression
Obesity increases the risk of Cancers of the esophagus, colon, rectum, liver, gall bladder, pancreas, kidney, stomach, prostate, breast, uterus, cervix and ovary as well as lymphomas and multiple myeloma. N Engl J Med. 2003 Apr 24;348(17):1625-38. In the woman, obesity increases the chances of infertility heart defects in fetus by 2 fold neural tube defects by 3 fold miscarriage by 3 fold gestational diabetes by 4 fold pre eclampsia by 2-3 fold venous thromboembolism by 10 fold in the presence of the ocp caesarean section intrapartum complications fetal macrosomia wound dehiscence post caesarean
Diabetes is an independent predictor of mortality from cancer of the colon, pancreas, breast (women) , liver and bladder (men). Am J Epidemiol. 2004 Jun 15;159(12):1160-7.
Relative risk of Diabetes in Obesity:
The relative risk of developing diabetes increases by
25% for every 1kg/m2 increase above 22 kg/m2
Illness Level Of evidence:
T2DM A Hypertension A Metabolic syndrome B Coronary Heart Disease A Obstructive Sleep apnea C Gout A Gall stones A Fatty liver B Asthma B Osteoarthritis knees A Breast cancer A Uterine cancer A Large intestine cancer B
Other diseases shown to be associated with obesity Multiple Myeloma Epidemiology. 2005 Sep;16(5):691-4. Kidney Stones JAMA. 2005 Jan 26;293(4):455-62
BENEFITS OF WEIGHT LOSS Loss of approximately 5% to 10% of body weight -- is also associated with significant improvements in cardiovascular risk factors including: -reductions in blood pressure ( N Engl J Med. 1978 Jan 5;298(1):1-6. ; Arch Intern Med. 1997 Mar 24;157(6):657-67. ; Hypertension. 2000 Feb;35(2):544-9. ; Ann Intern Med. 2001 Jan 2;134(1):1-11) -lipid levels (Am J Clin Nutr. 1992 Aug;56(2):320-8 ; Arch Intern Med. 2000 Jul 24;160(14):2150-8.) -inflammatory cytokines and markers (Circulation. 2002 Feb 19;105(7):804-9. ; Circulation. 2002 Feb 5;105(5):564-9.), as well as an improvement in glycaemia Ann Intern Med. 1993 Oct 1;119(7 Pt 2):722-6. ; and a decrease in the need for diabetic medications Diabetes Obes Metab. 2000 Jun;2(3):121-9. and mortality. A 7% weight loss in the DPP study was associated with a 58% reduction in the 4-year incidence of Type 2 diabetes. N Engl J Med. 2002 Feb 7;346(6):393-403.
Improvement in fasting glucose is directly related to the relative amount of weight lost. Metabolism. 1990 Sep;39(9):905-12. In women with obesity-related conditions, intentional weight loss of any amount was associated with a 20% reduction in all-cause mortality and a 30% to 40% reduction in diabetes-associated mortality For individuals with type 2 diabetes, an average intentional weight loss of 11% of initial body weight was associated with a 25% reduction in total mortality and a 28% reduction in cardiovascular and diabetes mortality
. This page was last updated on: 07/03/2007 |